[Combination therapy in Hodgkin's disease consisting of vincaleukoblastine, cyclophosphamide and natulan].
D000293:Adolescent; D000328:Adult; D000368:Aged; D003520:Cyclophosphamide / Q000008:administration & dosage* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005069:Evaluation Studies as Topic; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011344:Procarbazine / Q000008:administration & dosage* / Q000627:therapeutic use; D012075:Remission, Spontaneous; D013997:Time Factors; D014747:Vinblastine / Q000008:administration & dosage* / Q000627:therapeutic use
D011344:Procarbazine; D014747:Vinblastine; D003520:Cyclophosphamide
Leczenie wielolekowe ziarnicy złośliwej vinkaleukoblastyna, cyklofosfamidem i natulanem